ClinConnect ClinConnect Logo
Search / Trial NCT05261607

Analysis of the Evolution of Mortality in an Intensive Care Unit

Launched by HOSPITAL UNIVERSITARIO GETAFE · Feb 20, 2022

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Intensive Care Units Outcome Mortality

ClinConnect Summary

This clinical trial is studying how patient outcomes, specifically mortality rates, have changed over time for individuals admitted to an intensive care unit (ICU). The researchers want to examine data from an 18-bed medical-surgical ICU starting from 1991 and continuing through 2026. By analyzing this information, they aim to better understand the effectiveness of different treatment approaches, particularly for critically ill patients who often require advanced medical care and technology.

Anyone who has been admitted to the ICU may be eligible to participate in this study, as there are no specific exclusions. Participants can expect their health data to be reviewed as part of this research, which could help improve care for future ICU patients. This trial is currently recruiting, and it highlights the importance of understanding how ICU practices have evolved to enhance patient recovery and survival rates over the years.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Patients admitted to intensive care unit
  • Exclusion Criteria:
  • • None

About Hospital Universitario Getafe

Hospital Universitario Getafe is a leading healthcare institution located in Getafe, Spain, dedicated to providing high-quality medical services and advancing clinical research. As a clinical trial sponsor, the hospital emphasizes innovation and scientific rigor in its research initiatives, aiming to improve patient outcomes through the development of novel therapeutic approaches. With a multidisciplinary team of experienced healthcare professionals and researchers, Hospital Universitario Getafe is committed to fostering collaboration and integrating cutting-edge technology in its clinical trials, ensuring ethical standards and adherence to regulatory guidelines.

Locations

Getafe, Madrid, Spain

Patients applied

0 patients applied

Trial Officials

Fernando Frutos-Vivar, MD

Principal Investigator

Hospital Universitario de Getafe

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials